Structure Therapeutics Inc. Share Price

Structure Therapeutics Inc. Share Price

NASDAQ: GPCR | Mid Cap
$21.93
+$0.45 (2.09%) Last updated on 29 Oct, 2026 | 19:56 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Structure Therapeutics Inc. Stock Performance

Open
$21.57
Prev. Close
$21.48
Circuit Range
N/A
Day Range
$21.53 - $22.00
Year Range
$20.56 - $94.90
Volume
5,877
Average Traded
$21.77

Structure Therapeutics Inc. Share Price Today

As of 29 October 2026, Structure Therapeutics Inc.'s share price is $21.93. The stock opened at $21.57, compared to its previous close of $21.48. During today's trading session, Structure Therapeutics Inc.'s share price traded between $21.53 and $22.00, with an average price of $21.77. Over the past 52 weeks, the stock has recorded a high of $94.90 and a low of $20.56. In terms of performance, Structure Therapeutics Inc.'s share price has declined by 46.98% over the last six months and is down 34.23% on a year-on-year basis.

Structure Therapeutics Inc. Share Price Chart

Line chart of the Structure Therapeutics Inc. price trend over the selected period. The price rose overall, ranging from 21.47 to 21.96, ending at 21.96.
$21.53$22.00
L
Show Current Price
H

Structure Therapeutics Inc. Stock Fundamentals & Key Indicators

Market Cap
$3.89B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.01
Revenue (TTM)
$0.00
Return On Equity (TTM)
-15.86%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-61.56%

Structure Therapeutics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$65.71$33.00-$75.97-$106.16
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A150.22%-330.21%-39.74%

Structure Therapeutics Inc. Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.00$0.00$0.00
Net Profit-$89.62-$122.53-$141.20
Net Profit MarginN/AN/AN/A
Income ChangeN/A-36.72%-15.24%

About Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Structure Therapeutics Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$31.00
$22.00
-29.51%
Sep 2026
$46.35
$31.21
-36.50%
Aug 2026
$48.03
$49.15
+2.35%
Jul 2026
$54.32
$48.02
-10.64%
Jun 2026
$39.53
$53.74
+36.67%
May 2026
$43.86
$39.32
-4.93%
Apr 2026
$49.46
$41.36
-14.33%
Mar 2026
$61.88
$48.28
-23.43%
Feb 2026
$87.60
$63.05
-28.62%
Jan 2026
$69.80
$88.33
+26.96%
Dec 2025
$34.98
$69.58
+95.00%
Nov 2025
$33.20
$35.68
+7.00%

GPCR Share Price FAQs